sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Pharmaceuticals / Intravenous Iron Drugs

Intravenous Iron Drugs Market By Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, and Others) and Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Jun-2020
  • Total Pages: 188
  • Report Code: FAF-1201
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the intravenous iron drugs industry. The report analyzes and declares the historical and current trends analysis of the intravenous iron drugs industry and subsequently recommends the projected trends anticipated to be observed in the intravenous iron drugs market during the upcoming years.

The intravenous iron drugs market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire intravenous iron drugs market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the intravenous iron drugs industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the intravenous iron drugs industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the intravenous iron drugs market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the intravenous iron drugs industry. The intravenous iron drugs market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the intravenous iron drugs sector. Key strategic developments in the intravenous iron drugs market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the intravenous iron drugs market are appropriately highlighted in the report.

The intravenous iron drugs market research report delivers an acute valuation and taxonomy of the intravenous iron drugs industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the intravenous iron drugs industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the intravenous iron drugs industry is provided for the leading economies of the world.

Iron is one of the essential element in many vital biological processes in human body. Iron plays an important role in synthesis of heme, which outlines the basic component of Hb, the oxygen carrier in the blood. Intravenous iron is considered superior to the oral iron supplements and are considered to have faster and higher increase in the hemoglobin and refilling of body iron reserves. Intravenous iron drug directly circulates in the human body, oral iron supplements are first digested in the stomach and then absorbed in the blood flow.

In recent years, the number of anemia and iron deficient patients has increased in recent years. This has boosted the demand for iron supplements in the global healthcare market. In turn, driving the global intravenous iron drugs market. However, cost of oral iron supplements is less than intravenous iron drugs which hampered the wide spread adoption of intravenous iron drugs in the global healthcare market. Moreover, intravenous iron drugs are often prescribed based the patients physiology, which may affect the intravenous iron drug market.

The intravenous iron drugs market is segmented based on product, application, and region. On the basis of product, the market is classified into iron dextran, iron sucrose, ferric carboxymaltose, and others. On the basis of application, the market is classified into chronic kidney disease, inflammatory bowel disease, cancer, and others.

Some of the essential players operating in the intravenous iron drugs market, but not restricted to include Allergan Inc., Daiichi Sankyo Company Ltd., Rockwell Medical Technologies Inc., AMAG Pharmaceuticals Inc., Sanofi, Fresenius Medical Care AG & Co., Vifor Pharma Management Ltd., Pharmacosmos A/S, Shield Therapeutics Plc, American Regent Inc., and others.

The taxonomy of the intravenous iron drugs industry by its scope and segmentation is as follows:

Global Intravenous Iron Drugs Market: By Product Segmentation Analysis

  • Iron Dextran
  • Iron Sucrose
  • Ferric Carboxymaltose
  • Others

Global Intravenous Iron Drugs Market: By Application Segmentation Analysis

  • Chronic Kidney Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Others

Global Intravenous Iron Drugs Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Intravenous Iron Drugs market – Product Analysis
    1. 2.1. Global Intravenous Iron Drugs Market–ProductOverview
    2. 2.2. Global Intravenous Iron Drugs Market Share, by Product, 2019 & 2026 (USD Million)
    3. 2.3. Iron Dextran
      1. 2.3.1. Global Iron Dextran Intravenous Iron Drugs Market,2016-2026 (USD Million)
    4. 2.4. Iron Sucrose
      1. 2.4.1. Global Iron Sucrose Intravenous Iron Drugs Market,2016-2026 (USD Million)
    5. 2.5. Ferric Carboxymaltose
      1. 2.5.1. Global Ferric Carboxymaltose Intravenous Iron Drugs Market,2016-2026 (USD Million)
    6. 2.6. Others
      1. 2.6.1. Global Others Intravenous Iron Drugs Market,2016-2026 (USD Million)
  3. CHAPTER 3. Intravenous Iron Drugs market – Application Analysis
    1. 3.1. Global Intravenous Iron Drugs Market–Application Overview
    2. 3.2. Global Intravenous Iron Drugs Market Share, by Application, 2019 & 2026 (USD Million)
    3. 3.3. Chronic Kidney Disease
      1. 3.3.1. Global Chronic Kidney Disease Intravenous Iron Drugs Market,2016-2026 (USD Million)
    4. 3.4. Inflammatory Bowel Disease
      1. 3.4.1. Global Inflammatory Bowel Disease Intravenous Iron Drugs Market,2016-2026 (USD Million)
    5. 3.5. Cancer
      1. 3.5.1. Global Cancer Intravenous Iron Drugs Market,2016-2026 (USD Million)
    6. 3.6. Others
      1. 3.6.1. Global Others Intravenous Iron Drugs Market,2016-2026 (USD Million)
  4. CHAPTER 4. Intravenous Iron Drugs market – Regional Analysis
    1. 4.1. Global Intravenous Iron Drugs MarketRegionalOverview
    2. 4.2. Global Intravenous Iron Drugs Market Share, by Region, 2019 & 2026 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Intravenous Iron Drugs Market size and forecast, 2016-2026
      2. 4.3.2. North America Intravenous Iron Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.3.3. North America Intravenous Iron Drugs Market, by Product, 2016-2026
        1. 4.3.3.1. North America Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
      4. 4.3.4. North America Intravenous Iron Drugs Market, by Application, 2016-2026
        1. 4.3.4.1. North America Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 4.4. Europe
      1. 4.4.1. Europe Intravenous Iron Drugs Market size and forecast, 2016-2026
      2. 4.4.2. Europe Intravenous Iron Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.4.3. Europe Intravenous Iron Drugs Market, by Product, 2016-2026
        1. 4.4.3.1. Europe Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
      4. 4.4.4. Europe Intravenous Iron Drugs Market, by Application, 2016-2026
        1. 4.4.4.1. Europe Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2026 (USD Million)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2026 (USD Million)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2026 (USD Million)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2026 (USD Million)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Intravenous Iron Drugs Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Intravenous Iron Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.5.3. Asia Pacific Intravenous Iron Drugs Market, by Product, 2016-2026
        1. 4.5.3.1. Asia Pacific Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
      4. 4.5.4. Asia Pacific Intravenous Iron Drugs Market, by Application, 2016-2026
        1. 4.5.4.1. Asia Pacific Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2026 (USD Million)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2026 (USD Million)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2026 (USD Million)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 4.6. Latin America
      1. 4.6.1. Latin America Intravenous Iron Drugs Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Intravenous Iron Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.6.3. Latin America Intravenous Iron Drugs Market, by Product, 2016-2026
        1. 4.6.3.1. Latin America Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
      4. 4.6.4. Latin America Intravenous Iron Drugs Market, by Application, 2016-2026
        1. 4.6.4.1. Latin America Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Intravenous Iron Drugs Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Intravenous Iron Drugs Market, by Country, 2019 & 2026 (USD Million)
      3. 4.7.3. The Middle-East and Africa Intravenous Iron Drugs Market, by Product, 2016-2026
        1. 4.7.3.1. The Middle-East and Africa Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
      4. 4.7.4. The Middle-East and Africa Intravenous Iron Drugs Market, by Application, 2016-2026
        1. 4.7.4.1. The Middle-East and Africa Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  5. CHAPTER 5. Intravenous Iron Drugs market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. Allergan Inc.
      1. 6.1.1. Company Overview
      2. 6.1.2. Allergan Inc. Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Daiichi Sankyo Company Ltd.
      1. 6.2.1. Company Overview
      2. 6.2.2. Daiichi Sankyo Company Ltd. Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Rockwell Medical Technologies Inc.
      1. 6.3.1. Company Overview
      2. 6.3.2. Rockwell Medical Technologies Inc. Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. AMAG Pharmaceuticals Inc.
      1. 6.4.1. Company Overview
      2. 6.4.2. AMAG Pharmaceuticals Inc. Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Sanofi
      1. 6.5.1. Company Overview
      2. 6.5.2. Sanofi Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Fresenius Medical Care AG & Co.
      1. 6.6.1. Company Overview
      2. 6.6.2. Fresenius Medical Care AG & Co. Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Vifor Pharma Management Ltd.
      1. 6.7.1. Company Overview
      2. 6.7.2. Vifor Pharma Management Ltd. Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. Pharmacosmos A/S
      1. 6.8.1. Company Overview
      2. 6.8.2. Pharmacosmos A/S Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Shield Therapeutics Plc
      1. 6.9.1. Company Overview
      2. 6.9.2. Shield Therapeutics Plc Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. American Regent Inc.
      1. 6.10.1. Company Overview
      2. 6.10.2. American Regent Inc. Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Intravenous Iron Drugs — Industry Analysis
    1. 7.1. Intravenous Iron Drugs Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Intravenous Iron Drugs Market – Attractiveness Analysis
      1. 7.4.1. By Product
      2. 7.4.2. By Application
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global  Intravenous Iron Drugs Market, 2016-2026(USD Million)
        FIG. 2 Global  Intravenous Iron Drugs MarketShare, by Product, 2019 & 2026 (USD Million)
        FIG. 3 Global Iron Dextran Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 4 Global Iron Sucrose Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 5 Global Ferric Carboxymaltose Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 6 Global Others Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 7 Global  Intravenous Iron Drugs MarketShare, by Application, 2019 & 2026 (USD Million)
        FIG. 8 Global Chronic Kidney Disease Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 9 Global Inflammatory Bowel Disease Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 10 Global Cancer Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 11 Global Others Intravenous Iron Drugs Market,2016-2026 (USD Million)
        FIG. 12 Global  Intravenous Iron Drugs MarketShare, by Region, 2019 & 2026
        FIG. 13 North America Intravenous Iron Drugs Market, 2016-2026
        FIG. 14 U.S. Intravenous Iron Drugs Market, 2016-2026
        FIG. 15 Canada Intravenous Iron Drugs Market, 2016-2026
        FIG. 16 Europe Intravenous Iron Drugs Market, 2016-2026
        FIG. 17 Germany Intravenous Iron Drugs Market, 2016-2026
        FIG. 18 France Intravenous Iron Drugs Market, 2016-2026
        FIG. 19 U.K. Intravenous Iron Drugs Market, 2016-2026
        FIG. 20 Italy Intravenous Iron Drugs Market, 2016-2026
        FIG. 21 Spain Intravenous Iron Drugs Market, 2016-2026
        FIG. 22 Rest of Europe Intravenous Iron Drugs Market, 2016-2026
        FIG. 23 Asia Pacific Intravenous Iron Drugs Market, 2016-2026
        FIG. 24 China Intravenous Iron Drugs Market, 2016-2026
        FIG. 25 Japan Intravenous Iron Drugs Market, 2016-2026
        FIG. 26 India Intravenous Iron Drugs Market, 2016-2026
        FIG. 27 South  Korea Intravenous Iron Drugs Market, 2016-2026
        FIG. 28 South-East Asia Intravenous Iron Drugs Market, 2016-2026
        FIG. 29 Rest of Asia Pacific Intravenous Iron Drugs Market, 2016-2026
        FIG. 30 Latin America Intravenous Iron Drugs Market, 2016-2026
        FIG. 31 Brazil Intravenous Iron Drugs Market, 2016-2026
        FIG. 32 Mexico Intravenous Iron Drugs Market, 2016-2026
        FIG. 33 Rest of Latin America Intravenous Iron Drugs Market, 2016-2026
        FIG. 34 The Middle-East and Africa Intravenous Iron Drugs Market, 2016-2026
        FIG. 35 GCC Countries Intravenous Iron Drugs Market, 2016-2026
        FIG. 36 South Africa Intravenous Iron Drugs Market, 2016-2026
        FIG. 37 Rest of Middle-East Africa Intravenous Iron Drugs Market, 2016-2026
        FIG. 38 Competitor Market Share –  Revenue
        FIG. 39 Allergan Inc.  Revenue and Growth Rate
        FIG. 40 Allergan Inc. Market Share
        FIG. 41 Daiichi Sankyo Company Ltd.  Revenue and Growth Rate
        FIG. 42 Daiichi Sankyo Company Ltd. Market Share
        FIG. 43 Rockwell Medical Technologies Inc.  Revenue and Growth Rate
        FIG. 44 Rockwell Medical Technologies Inc. Market Share
        FIG. 45 AMAG Pharmaceuticals Inc.  Revenue and Growth Rate
        FIG. 46 AMAG Pharmaceuticals Inc. Market Share
        FIG. 47 Sanofi  Revenue and Growth Rate
        FIG. 48 Sanofi Market Share
        FIG. 49 Fresenius Medical Care AG & Co.  Revenue and Growth Rate
        FIG. 50 Fresenius Medical Care AG & Co. Market Share
        FIG. 51 Vifor Pharma Management Ltd.  Revenue and Growth Rate
        FIG. 52 Vifor Pharma Management Ltd. Market Share
        FIG. 53 Pharmacosmos A/S  Revenue and Growth Rate
        FIG. 54 Pharmacosmos A/S Market Share
        FIG. 55 Shield Therapeutics Plc  Revenue and Growth Rate
        FIG. 56 Shield Therapeutics Plc Market Share
        FIG. 57 American Regent Inc.  Revenue and Growth Rate
        FIG. 58 American Regent Inc. Market Share
        FIG. 59 Market Dynamics
        FIG. 60 Global  Intravenous Iron Drugs – Value Chain Analysis
        FIG. 61 Technology Roadmap and Timeline
        FIG. 62 Market Attractiveness Analysis – By Product
        FIG. 63 Market Attractiveness Analysis – By Application
        FIG. 64 Market Attractiveness Analysis – By Region
        FIG. 65 Market Channel
        FIG. 66 Marketing Channel Development Trend
        FIG. 67 Growth in World Gross Product, 2008-2019

        List of Tables

        TABLE 1 Global  Intravenous Iron Drugs Market, 2019 & 2026 (USD Million)
        TABLE 2 Global  Intravenous Iron Drugs market, by Product, 2016-2026 (USD Million)
        TABLE 3 Global  Intravenous Iron Drugs market, by Application, 2016-2026 (USD Million)
        TABLE 4 Global  Intravenous Iron Drugs market, by Region, 2016-2026 (USD Million)
        TABLE 5 North America Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
        TABLE 6 North America Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
        TABLE 7 Europe Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
        TABLE 8 Europe Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
        TABLE 9 Asia Pacific Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
        TABLE 10 Asia Pacific Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
        TABLE 11 Latin America Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
        TABLE 12 Latin America Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
        TABLE 13 The Middle-East and Africa Intravenous Iron Drugs Market, by Product, 2016-2026 (USD Million)
        TABLE 14 The Middle-East and Africa Intravenous Iron Drugs Market, by Application, 2016-2026 (USD Million)
        TABLE 15 Global  Intravenous Iron Drugs Market - Company  Revenue Analysis 2016-2019 (USD Million)
        TABLE 16 Global  Intravenous Iron Drugs Market - Company  Revenue Share Analysis 2016-2019(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities

Key Insights from Primary Research

  • As per our primary respondents, the global intravenous iron drugs market is expected to grow at a CAGR of nearly 8% over the projected period.
  • Rising demand for intravenous iron drugs for treating iron-deficiency anemia is a key growth fueling factor for the market.
  • On the basis of type, the ferric carboxymaltose segment is expected to dominate the global market, while constituting a market share of approximately 40% in 2019.
  • Increasing cases of iron-deficiency among women has also created the demand for IV iron drugs and is likely to increase with increase in health consciousness among women. 
  • By geography, the North America region held a major share in the global market accounting for a market share for 35%.

Key Recommendations from Analysts

  • According to our healthcare analysts, increased healthcare spending has contributed to increasing the demand for iron supplements. This is driving the IV iron drugs market.
  • Moreover, research and development and clinical trials is predicted to create new avenues for the IV iron drugs market. Also, wider commercialization of IV iron drugs is also anticipated to create new avenues for the global market.
  • Our analysts estimate that the Asia Pacific region is predicted to foresee a rapid growth attributed to the growing healthcare spending and increasing number of hospitals in China and India.
  • Based on type, the iron sucrose segment is expected to witness the highest CAGR over the projected period in the IV iron drugs market.
  • In terms of application, the cancer segment is predicted to witness a rapid growth in future years. Loss of blood during cancer treatment often results in decreased Hb concentration in patients, which may fuel the demand for IV iron drugs.

Global Intravenous Iron Drugs Market Share Analysis by Type

Industry Major Market Players

  • Allergan Inc.
  • Daiichi Sankyo Company Ltd.
  • Rockwell Medical Technologies Inc.
  • AMAG Pharmaceuticals Inc.
  • Sanofi
  • Fresenius Medical Care AG & Co.
  • Vifor Pharma Management Ltd.
  • Pharmacosmos A/S
  • Shield Therapeutics Plc
  • American Regent Inc.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions